nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.0327	0.0575	CcSEcCtD
Ropivacaine—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0216	0.0379	CcSEcCtD
Ropivacaine—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0203	0.0357	CcSEcCtD
Ropivacaine—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0188	0.033	CcSEcCtD
Ropivacaine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0257	CcSEcCtD
Ropivacaine—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0206	CcSEcCtD
Ropivacaine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0202	CcSEcCtD
Ropivacaine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0202	CcSEcCtD
Ropivacaine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0197	CcSEcCtD
Ropivacaine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0192	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00991	0.0174	CcSEcCtD
Ropivacaine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00969	0.017	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.00915	0.0212	CbGpPWpGaD
Ropivacaine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00899	0.0158	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00895	0.0157	CcSEcCtD
Ropivacaine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.0156	CcSEcCtD
Ropivacaine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00866	0.0152	CcSEcCtD
Ropivacaine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00853	0.015	CcSEcCtD
Ropivacaine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00821	0.0144	CcSEcCtD
Ropivacaine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00783	0.0138	CcSEcCtD
Ropivacaine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.0078	0.0137	CcSEcCtD
Ropivacaine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00754	0.0132	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.0074	0.0172	CbGpPWpGaD
Ropivacaine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00737	0.0129	CcSEcCtD
Ropivacaine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.0128	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.00707	0.0164	CbGpPWpGaD
Ropivacaine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.0123	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.0068	0.0158	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.0068	0.0158	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00677	0.0157	CbGpPWpGaD
Ropivacaine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00675	0.0119	CcSEcCtD
Ropivacaine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00666	0.0117	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00658	0.0116	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.00655	0.0152	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.00655	0.0152	CbGpPWpGaD
Ropivacaine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00654	0.0115	CcSEcCtD
Ropivacaine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00654	0.0115	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00653	0.0152	CbGpPWpGaD
Ropivacaine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00651	0.0114	CcSEcCtD
Ropivacaine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00649	0.0114	CcSEcCtD
Ropivacaine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00637	0.0112	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00622	0.0144	CbGpPWpGaD
Ropivacaine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00601	0.0106	CcSEcCtD
Ropivacaine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.0105	CcSEcCtD
Ropivacaine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.0104	CcSEcCtD
Ropivacaine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.0103	CcSEcCtD
Ropivacaine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.00981	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00547	0.0127	CbGpPWpGaD
Ropivacaine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00538	0.00945	CcSEcCtD
Ropivacaine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00535	0.0094	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00528	0.0123	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00525	0.0122	CbGpPWpGaD
Ropivacaine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00922	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00523	0.0122	CbGpPWpGaD
Ropivacaine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00512	0.00899	CcSEcCtD
Ropivacaine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.0089	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00505	0.0117	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00503	0.0117	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00503	0.0117	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00503	0.0117	CbGpPWpGaD
Ropivacaine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00881	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00501	0.0116	CbGpPWpGaD
Ropivacaine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00864	CcSEcCtD
Ropivacaine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00859	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00485	0.0113	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00485	0.0113	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00485	0.0113	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00485	0.0113	CbGpPWpGaD
Ropivacaine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.0085	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00483	0.0112	CbGpPWpGaD
Ropivacaine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.00847	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00481	0.0112	CbGpPWpGaD
Ropivacaine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.00842	CcSEcCtD
Ropivacaine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00837	CcSEcCtD
Ropivacaine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.00826	CcSEcCtD
Ropivacaine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00823	CcSEcCtD
Ropivacaine—SCN10A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00468	0.0109	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00468	0.0109	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00462	0.0107	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00462	0.0107	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.00461	0.0107	CbGpPWpGaD
Ropivacaine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00455	0.008	CcSEcCtD
Ropivacaine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.00794	CcSEcCtD
Ropivacaine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.00791	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00446	0.0103	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00446	0.0103	CbGpPWpGaD
Ropivacaine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.0078	CcSEcCtD
Ropivacaine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.0078	CcSEcCtD
Ropivacaine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.0078	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00444	0.0103	CbGpPWpGaD
Ropivacaine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00443	0.00777	CcSEcCtD
Ropivacaine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00771	CcSEcCtD
Ropivacaine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00754	CcSEcCtD
Ropivacaine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00748	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00425	0.00987	CbGpPWpGaD
Ropivacaine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00423	0.00743	CcSEcCtD
Ropivacaine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00732	CcSEcCtD
Ropivacaine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.00726	CcSEcCtD
Ropivacaine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.00723	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00406	0.00944	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00405	0.00941	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.0039	0.00907	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.0039	0.00907	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.0039	0.00907	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00388	0.00681	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00388	0.009	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00386	0.00897	CbGpPWpGaD
Ropivacaine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00676	CcSEcCtD
Ropivacaine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.00672	CcSEcCtD
Ropivacaine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00667	CcSEcCtD
Ropivacaine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.00665	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00376	0.00874	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00376	0.00874	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00375	0.0087	CbGpPWpGaD
Ropivacaine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.00658	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00373	0.00867	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00372	0.00865	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00372	0.00865	CbGpPWpGaD
Ropivacaine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.0064	CcSEcCtD
Ropivacaine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.0064	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00359	0.00834	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00359	0.00834	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00359	0.00833	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00359	0.00833	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00359	0.00833	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00358	0.0083	CbGpPWpGaD
Ropivacaine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.00616	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00612	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00346	0.00803	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00346	0.00803	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00343	0.00797	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00341	0.00792	CbGpPWpGaD
Ropivacaine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00594	CcSEcCtD
Ropivacaine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00591	CcSEcCtD
Ropivacaine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00591	CcSEcCtD
Ropivacaine—SCN2A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.0033	0.00766	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.0033	0.00766	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00329	0.00764	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00318	0.00738	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00318	0.00738	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00551	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00313	0.00727	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00312	0.00725	CbGpPWpGaD
Ropivacaine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00537	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00303	0.00704	CbGpPWpGaD
Ropivacaine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00529	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00299	0.00694	CbGpPWpGaD
Ropivacaine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00512	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.0029	0.00673	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00289	0.00672	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00287	0.00667	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00287	0.00667	CbGpPWpGaD
Ropivacaine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00495	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00279	0.00647	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00279	0.00647	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00277	0.00643	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00277	0.00643	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00277	0.00642	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00276	0.0064	CbGpPWpGaD
Ropivacaine—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00271	0.00629	CbGpPWpGaD
Ropivacaine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00476	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00269	0.00624	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00269	0.00624	CbGpPWpGaD
Ropivacaine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00472	CcSEcCtD
Ropivacaine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00471	CcSEcCtD
Ropivacaine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00469	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00266	0.00617	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00266	0.00617	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00265	0.00615	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00256	0.00595	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00256	0.00595	CbGpPWpGaD
Ropivacaine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00444	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00252	0.00586	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00243	0.00565	CbGpPWpGaD
Ropivacaine—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00229	0.00533	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00224	0.00519	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00223	0.00518	CbGpPWpGaD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—focal segmental glomerulosclerosis	0.00216	0.00502	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00213	0.00495	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00205	0.00476	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00205	0.00476	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00198	0.00459	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00198	0.00459	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00195	0.00452	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00189	0.00439	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.0018	0.00418	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00173	0.00403	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00163	0.00378	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.00154	0.00357	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.0014	0.00326	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00139	0.00323	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00134	0.00311	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00132	0.00306	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00129	0.00299	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00129	0.00299	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00126	0.00293	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00124	0.00288	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00124	0.00288	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00122	0.00284	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00121	0.00281	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00121	0.00281	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00117	0.00271	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00117	0.00271	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00116	0.0027	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00099	0.0023	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000947	0.0022	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00094	0.00218	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00091	0.00211	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00091	0.00211	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000899	0.00209	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000877	0.00204	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000877	0.00204	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000873	0.00203	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000873	0.00203	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000864	0.00201	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000864	0.00201	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000833	0.00193	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000833	0.00193	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00082	0.00191	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.00072	0.00167	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000706	0.00164	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000676	0.00157	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000649	0.00151	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000649	0.00151	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000639	0.00148	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000626	0.00145	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000626	0.00145	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000617	0.00143	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000585	0.00136	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000582	0.00135	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000557	0.00129	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000535	0.00124	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000535	0.00124	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000516	0.0012	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000516	0.0012	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.00044	0.00102	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000363	0.000842	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000337	0.000783	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000297	0.000689	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000255	0.000592	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000225	0.000521	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000207	0.00048	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000206	0.000478	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000177	0.000412	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000176	0.000409	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000156	0.000362	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	0.000156	0.000361	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00015	0.000349	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000144	0.000334	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000135	0.000314	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	0.000133	0.000309	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000132	0.000307	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000122	0.000283	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000116	0.000269	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	0.000108	0.000251	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	0.000102	0.000237	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000102	0.000237	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.4e-05	0.000218	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	9.25e-05	0.000215	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	9.16e-05	0.000213	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	7.84e-05	0.000182	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	7.1e-05	0.000165	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	7.07e-05	0.000164	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	6.05e-05	0.000141	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	6.02e-05	0.00014	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	4.64e-05	0.000108	CbGpPWpGaD
